BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 24287935)

  • 1. Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants.
    Di Gioia D; Aloisio I; Mazzola G; Biavati B
    Appl Microbiol Biotechnol; 2014 Jan; 98(2):563-77. PubMed ID: 24287935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Bifidobacterium spp. strains for the treatment of enteric disorders in newborns.
    Aloisio I; Santini C; Biavati B; Dinelli G; Cencič A; Chingwaru W; Mogna L; Di Gioia D
    Appl Microbiol Biotechnol; 2012 Dec; 96(6):1561-76. PubMed ID: 22588500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: a comparison between one-species and three-species administration.
    Ishizeki S; Sugita M; Takata M; Yaeshima T
    Anaerobe; 2013 Oct; 23():38-44. PubMed ID: 23988359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology and probiotic impact of the newborn and young children intestinal microflora.
    Bezirtzoglou E; Stavropoulou E
    Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities for improving the health and nutrition of the human infant by probiotics.
    Salminen S; Isolauri E
    Nestle Nutr Workshop Ser Pediatr Program; 2008; 62():223-33; discussion 233-7. PubMed ID: 18626203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast milk: a source of bifidobacteria for infant gut development and maturation?
    Gueimonde M; Laitinen K; Salminen S; Isolauri E
    Neonatology; 2007; 92(1):64-6. PubMed ID: 17596738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Bifidobacterium microbiota in one-month-old Brazilian newborns.
    Grześkowiak Ł; Sales Teixeira TF; Bigonha SM; Lobo G; Salminen S; Ferreira CL
    Anaerobe; 2015 Oct; 35(Pt B):54-8. PubMed ID: 26204793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of formula composition on the development of infant gut microbiota.
    Hascoët JM; Hubert C; Rochat F; Legagneur H; Gaga S; Emady-Azar S; Steenhout PG
    J Pediatr Gastroenterol Nutr; 2011 Jun; 52(6):756-62. PubMed ID: 21593648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany.
    Grześkowiak Ł; Grönlund MM; Beckmann C; Salminen S; von Berg A; Isolauri E
    Anaerobe; 2012 Feb; 18(1):7-13. PubMed ID: 21979491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bifidobacteria and Their Health-Promoting Effects.
    Hidalgo-Cantabrana C; Delgado S; Ruiz L; Ruas-Madiedo P; Sánchez B; Margolles A
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics, gut microbiota and health.
    Butel MJ
    Med Mal Infect; 2014 Jan; 44(1):1-8. PubMed ID: 24290962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Microbiology: The Role of
    Bozzi Cionci N; Baffoni L; Gaggìa F; Di Gioia D
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30423810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits.
    Picard C; Fioramonti J; Francois A; Robinson T; Neant F; Matuchansky C
    Aliment Pharmacol Ther; 2005 Sep; 22(6):495-512. PubMed ID: 16167966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease.
    Grönlund MM; Gueimonde M; Laitinen K; Kociubinski G; Grönroos T; Salminen S; Isolauri E
    Clin Exp Allergy; 2007 Dec; 37(12):1764-72. PubMed ID: 17941914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bosom Buddies: The Symbiotic Relationship Between Infants and Bifidobacterium longum ssp. longum and ssp. infantis. Genetic and Probiotic Features.
    Arboleya S; Stanton C; Ryan CA; Dempsey E; Ross PR
    Annu Rev Food Sci Technol; 2016; 7():1-21. PubMed ID: 26934170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA.
    Campeotto F; Suau A; Kapel N; Magne F; Viallon V; Ferraris L; Waligora-Dupriet AJ; Soulaines P; Leroux B; Kalach N; Dupont C; Butel MJ
    Br J Nutr; 2011 Jun; 105(12):1843-51. PubMed ID: 21426607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary architecture of the infant-adapted group of Bifidobacterium species associated with the probiotic function.
    Kwak MJ; Kwon SK; Yoon JK; Song JY; Seo JG; Chung MJ; Kim JF
    Syst Appl Microbiol; 2016 Oct; 39(7):429-439. PubMed ID: 27524178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifidobacteria attenuate the development of metabolic disorders, with inter- and intra-species differences.
    Zhu G; Ma F; Wang G; Wang Y; Zhao J; Zhang H; Chen W
    Food Funct; 2018 Jun; 9(6):3509-3522. PubMed ID: 29892745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors involved in the colonization and survival of bifidobacteria in the gastrointestinal tract.
    González-Rodríguez I; Ruiz L; Gueimonde M; Margolles A; Sánchez B
    FEMS Microbiol Lett; 2013 Mar; 340(1):1-10. PubMed ID: 23181549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.